GAGE2B | G antigen 2B | Xp11.23 not on reference assembly | 2.073 | 0.548 | 0
|
GAGE1 | G antigen 1 | Xp11.23 | 2.011 | 0.575 | 0
|
GAGE12D | G antigen 12D | Xp11.23 | 1.965 | 0.596 | 0
|
FTHL17 | ferritin, heavy polypeptide-like 17 | Xp21.2 | 1.962 | 0.639 | 0
|
LINC00200 | long intergenic non-protein coding RNA 200 | 10p15.3 | 1.939 | 0.475 | 0
|
GAGE2A | G antigen 2A | Xp11.23 | 1.936 | 0.549 | 0
|
SSX2 | synovial sarcoma, X breakpoint 2 | Xp11.22 | 1.904 | 0.628 | 0
|
NAA11 | N(alpha)-acetyltransferase 11, NatA catalytic subunit | 4q21.23 | 1.883 | 0.576 | 0
|
DCAF4L2 | DDB1 and CUL4 associated factor 4-like 2 | 8q21.3 | 1.875 | 0.637 | 0
|
GAGE2D | G antigen 2D | Xp11.23 not on reference assembly | 1.854 | 0.58 | 0
|
DPPA2 | developmental pluripotency associated 2 | 3q13.13 | 1.854 | 0.512 | 0
|
PAGE2 | P antigen family, member 2 (prostate associated) | Xp11.22 | 1.822 | 0.498 | 0
|
SSX1 | synovial sarcoma, X breakpoint 1 | Xp11.23 | 1.759 | 0.557 | 0
|
GAGE12J | G antigen 12J | Xp11.23 | 1.751 | 0.525 | 0
|
GAGE4 | G antigen 4 | Xp11.4-p11.2 not on reference assembly | 1.732 | 0.533 | 0
|
MMP23A | matrix metallopeptidase 23A (pseudogene) | 1p36.3 | 1.73 | 0.28 | 4.4e-09
|
ZNF716 | zinc finger protein 716 | 7p11.1 | 1.728 | 0.541 | 0
|
SPANXC | SPANX family, member C | Xq27.2 | 1.726 | 0.477 | 0
|
NXF2 | nuclear RNA export factor 2 | Xq22.1 | 1.713 | 0.474 | 0
|
GC | group-specific component (vitamin D binding protein) | 4q12-q13 | 1.704 | 0.324 | 9.66e-12
|
APOC3 | apolipoprotein C-III | 11q23.3 | 1.701 | 0.312 | 5.16e-11
|
CT45A5 | cancer/testis antigen family 45, member A5 | Xq26.3 | 1.698 | 0.514 | 0
|
XAGE2 | X antigen family, member 2 | Xp11.22 | 1.688 | 0.337 | 1.06e-12
|
CT83 | cancer/testis antigen 83 | Xq23 | 1.677 | 0.423 | 0
|
PHF2P1 | PHD finger protein 2 pseudogene 1 | 13q11 | 1.666 | 0.542 | 0
|
COX7B2 | cytochrome c oxidase subunit VIIb2 | 4p12 | 1.665 | 0.601 | 0
|
APOH | apolipoprotein H (beta-2-glycoprotein I) | 17q24.2 | 1.663 | 0.234 | 1.05e-06
|
BAGE | B melanoma antigen | 21p11.1 not on reference assembly | 1.658 | 0.576 | 0
|
REG1A | regenerating islet-derived 1 alpha | 2p12 | 1.642 | 0.376 | 8.15e-16
|
DSCR4 | Down syndrome critical region 4 | 21q22.2 | 1.637 | 0.463 | 0
|
CT45A1 | cancer/testis antigen family 45, member A1 | Xq26.3 | 1.62 | 0.455 | 0
|
BRDT | bromodomain, testis-specific | 1p22.1 | 1.619 | 0.313 | 4.92e-11
|
SAGE1 | sarcoma antigen 1 | Xq26 | 1.6 | 0.463 | 0
|
TUBA3C | tubulin, alpha 3c | 13q12.11 | 1.581 | 0.415 | 0
|
MAGEC1 | melanoma antigen family C1 | Xq26 | 1.559 | 0.53 | 0
|
HMX1 | H6 family homeobox 1 | 4p16.1 | 1.558 | 0.215 | 7.63e-06
|
SPRR2B | small proline-rich protein 2B | 1q21-q22 | 1.547 | 0.33 | 3.69e-12
|
CDH18 | cadherin 18, type 2 | 5p14.3 | 1.547 | 0.414 | 0
|
SSX4 | synovial sarcoma, X breakpoint 4 | Xp11.23 | 1.544 | 0.523 | 0
|
DLK1 | delta-like 1 homolog (Drosophila) | 14q32.2 | 1.533 | 0.141 | 0.00357
|
LCN15 | lipocalin 15 | 9q34.3 | 1.511 | 0.247 | 2.45e-07
|
DSCR8 | Down syndrome critical region 8 | 21q22.2 | 1.503 | 0.456 | 0
|
CELP | carboxyl ester lipase pseudogene | 9q34.2 | 1.492 | 0.197 | 4.23e-05
|
PRAC1 | prostate cancer susceptibility candidate 1 | 17q21 | 1.485 | 0.224 | 3.22e-06
|
PNLIPRP3 | pancreatic lipase-related protein 3 | 10q26.12 | 1.485 | 0.215 | 7.9e-06
|
FOXG1 | forkhead box G1 | 14q12 | 1.481 | 0.33 | 3.53e-12
|
CRISP2 | cysteine-rich secretory protein 2 | 6p12.3 | 1.463 | 0.285 | 2.39e-09
|
TCHHL1 | trichohyalin-like 1 | 1q21.3 | 1.445 | 0.351 | 1.09e-13
|
LCE3D | late cornified envelope 3D | 1q21 | 1.442 | 0.289 | 1.36e-09
|
TRDN | triadin | 6q22.31 | 1.426 | 0.371 | 2.39e-15
|
TMPRSS11F | transmembrane protease, serine 11F | 4q13.2 | 1.423 | 0.244 | 3.66e-07
|
LCE3E | late cornified envelope 3E | 1q21.3 | 1.413 | 0.246 | 2.86e-07
|
SPRR2C | small proline-rich protein 2C (pseudogene) | 1q21-q22 | 1.404 | 0.252 | 1.46e-07
|
MAGEC2 | melanoma antigen family C2 | Xq27 | 1.396 | 0.542 | 0
|
BPIFA1 | BPI fold containing family A, member 1 | 20q11.21 | 1.381 | 0.197 | 4.44e-05
|
DPP10 | dipeptidyl-peptidase 10 (non-functional) | 2q14.1 | 1.378 | 0.137 | 0.00453
|
GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 5q34 | 1.376 | 0.396 | 0
|
PRSS41 | protease, serine, 41 | 16p13.3 | 1.364 | 0.205 | 2.03e-05
|
HBE1 | hemoglobin, epsilon 1 | 11p15.5 | 1.343 | 0.37 | 3.2e-15
|
CNTNAP4 | contactin associated protein-like 4 | 16q23.1 | 1.334 | 0.402 | 0
|
CTAG2 | cancer/testis antigen 2 | Xq28 | 1.329 | 0.456 | 0
|
ESX1 | ESX homeobox 1 | Xq22.2 | 1.314 | 0.234 | 1.05e-06
|
PAGE2B | P antigen family, member 2B | Xp11.22 | 1.313 | 0.418 | 0
|
ZIC1 | Zic family member 1 | 3q24 | 1.313 | 0.326 | 6.93e-12
|
LINC00202-2 | long intergenic non-protein coding RNA 202-2 | 10p12.1 | 1.306 | 0.38 | 2.82e-16
|
AHSG | alpha-2-HS-glycoprotein | 3q27.3 | 1.301 | 0.269 | 1.9e-08
|
AADACL2 | arylacetamide deacetylase-like 2 | 3q25.1 | 1.288 | 0.114 | 0.0183
|
ADIPOQ | adiponectin, C1Q and collagen domain containing | 3q27 | 1.286 | 0.149 | 0.00202
|
ZNF560 | zinc finger protein 560 | 19p13.2 | 1.285 | 0.306 | 1.25e-10
|
NBPF6 | neuroblastoma breakpoint family, member 6 | 1p13.3 | 1.28 | 0.301 | 2.53e-10
|
AQP4 | aquaporin 4 | 18q11.2-q12.1 | 1.277 | 0.071 | 0.145
|
TP53TG3B | TP53 target 3B | 16p11.2 | 1.276 | 0.323 | 1.04e-11
|
CRNN | cornulin | 1q21 | 1.275 | 0.214 | 8.46e-06
|
B4GALNT2 | beta-1,4-N-acetyl-galactosaminyl transferase 2 | 17q21.33 | 1.27 | 0.114 | 0.0184
|
SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | 14q32.13 | 1.265 | 0.196 | 4.73e-05
|
UGT2A3 | UDP glucuronosyltransferase 2 family, polypeptide A3 | 4q13.2 | 1.263 | 0.16 | 0.000944
|
NR0B1 | nuclear receptor subfamily 0, group B, member 1 | Xp21.3 | 1.258 | 0.17 | 0.00042
|
CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 19q13.2 | 1.253 | 0.154 | 0.00146
|
GBA3 | glucosidase, beta, acid 3 (gene/pseudogene) | 4p15.2 | 1.253 | 0.394 | 0
|
PAX3 | paired box 3 | 2q36.1 | 1.247 | 0.239 | 6.64e-07
|
STON1-GTF2A1L | STON1-GTF2A1L readthrough | 2p16.3 | 1.241 | 0.03 | 0.54
|
WFDC12 | WAP four-disulfide core domain 12 | 20q13.12 | 1.23 | 0.252 | 1.39e-07
|
PAX7 | paired box 7 | 1p36.13 | 1.225 | 0.178 | 0.000221
|
KLK9 | kallikrein-related peptidase 9 | 19q13.33 | 1.218 | 0.229 | 1.86e-06
|
KLK12 | kallikrein-related peptidase 12 | 19q13.33 | 1.217 | 0.2 | 3.26e-05
|
CCL15-CCL14 | CCL15-CCL14 readthrough (NMD candidate) | 17q12 | 1.215 | 0.115 | 0.0176
|
FABP7 | fatty acid binding protein 7, brain | 6q22-q23 | 1.207 | 0.265 | 2.94e-08
|
FGG | fibrinogen gamma chain | 4q28 | 1.204 | 0.339 | 7.99e-13
|
LRTM1 | leucine-rich repeats and transmembrane domains 1 | 3p14.3 | 1.201 | 0.165 | 0.00063
|
KIAA0408 | KIAA0408 | 6q22.33 | 1.201 | 0.068 | 0.161
|
FGA | fibrinogen alpha chain | 4q28 | 1.192 | 0.356 | 4.2e-14
|
SLCO1B1 | solute carrier organic anion transporter family, member 1B1 | 12p12 | 1.191 | 0.437 | 0
|
IGFL3 | IGF-like family member 3 | 19q13.32 | 1.189 | 0.242 | 4.33e-07
|
NKX2-5 | NK2 homeobox 5 | 5q34 | 1.188 | 0.192 | 6.99e-05
|
TRIML2 | tripartite motif family-like 2 | 4q35.2 | 1.163 | 0.207 | 1.63e-05
|
SLC30A8 | solute carrier family 30 (zinc transporter), member 8 | 8q24.11 | 1.158 | 0.292 | 8.97e-10
|
LHFPL3-AS2 | LHFPL3 antisense RNA 2 | 7q22.3 | 1.156 | 0.31 | 6.96e-11
|
LRRC7 | leucine rich repeat containing 7 | 1p31.1 | 1.154 | 0.219 | 5.47e-06
|
PPAN-P2RY11 | PPAN-P2RY11 readthrough | 19p13.2 | 1.148 | 0.067 | 0.168
|
GLB1L3 | galactosidase, beta 1-like 3 | 11q25 | 1.143 | 0.262 | 4.18e-08
|
FGB | fibrinogen beta chain | 4q28 | 1.139 | 0.311 | 6.22e-11
|
SCGB2A1 | secretoglobin, family 2A, member 1 | 11q13 | 1.122 | 0.099 | 0.0411
|
LGSN | lengsin, lens protein with glutamine synthetase domain | 6q12 | 1.122 | 0.286 | 2.03e-09
|
FGF19 | fibroblast growth factor 19 | 11q13.1 | 1.116 | 0.18 | 0.000187
|
TBL1Y | transducin (beta)-like 1, Y-linked | Yp11.2 | 1.101 | 0.067 | 0.169
|
LGALS9B | lectin, galactoside-binding, soluble, 9B | 17p11.2 | 1.093 | 0.086 | 0.0747
|
FLG2 | filaggrin family member 2 | 1q21.3 | 1.087 | 0.178 | 0.000231
|
C6orf15 | chromosome 6 open reading frame 15 | 6p21 | 1.085 | 0.155 | 0.00133
|
MAGEA1 | melanoma antigen family A1 | Xq28 | 1.083 | 0.348 | 1.75e-13
|
TKTL1 | transketolase-like 1 | Xq28 | 1.079 | 0.236 | 8.85e-07
|
SPRR4 | small proline-rich protein 4 | 1q21.3 | 1.077 | 0.183 | 0.000153
|
CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 19q13.2 | 1.077 | 0.078 | 0.106
|
MRGPRX2 | MAS-related GPR, member X2 | 11p15.1 | 1.074 | 0.178 | 0.000223
|
HSFY2 | heat shock transcription factor, Y-linked 2 | Yq11.221 | 1.069 | 0.059 | 0.225
|
TUSC5 | tumor suppressor candidate 5 | 17p13.3 | 1.065 | 0 | 0.993
|
MAGEA10 | melanoma antigen family A10 | Xq28 | 1.065 | 0.364 | 1.01e-14
|
PIK3C2G | phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma | 12p12 | 1.065 | 0.11 | 0.0226
|
MAGEB2 | melanoma antigen family B2 | Xp21.3 | 1.059 | 0.343 | 4.49e-13
|
THEG | theg spermatid protein | 19p13.3 | 1.058 | 0.142 | 0.00324
|
SPRR2G | small proline-rich protein 2G | 1q21-q22 | 1.054 | 0.24 | 5.94e-07
|
C4BPA | complement component 4 binding protein, alpha | 1q32 | 1.053 | 0.202 | 2.8e-05
|
CTAG1B | cancer/testis antigen 1B | Xq28 | 1.051 | 0.334 | 1.73e-12
|
PGC | progastricsin (pepsinogen C) | 6p21.1 | 1.051 | 0.118 | 0.0148
|
SPINK6 | serine peptidase inhibitor, Kazal type 6 | 5q32 | 1.048 | 0.229 | 1.94e-06
|
C14orf105 | chromosome 14 open reading frame 105 | 14q22.2 | 1.045 | 0.08 | 0.0979
|
LINC00470 | long intergenic non-protein coding RNA 470 | 18p11.32 | 1.043 | 0.427 | 0
|
DAZ1 | deleted in azoospermia 1 | Yq11.223 | 1.041 | 0.131 | 0.00688
|
LRRTM3 | leucine rich repeat transmembrane neuronal 3 | 10q22.1 | 1.041 | 0.109 | 0.0249
|
TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 20q13.13 | 1.037 | 0.078 | 0.107
|
PWRN1 | Prader-Willi region non-protein coding RNA 1 | 15q11.2 | 1.036 | 0.057 | 0.24
|
GKN1 | gastrokine 1 | 2p13.3 | 1.034 | 0.087 | 0.0737
|
CDH16 | cadherin 16, KSP-cadherin | 16q22.1 | 1.029 | 0.204 | 2.17e-05
|
GLP2R | glucagon-like peptide 2 receptor | 17p13.3 | 1.021 | 0.034 | 0.479
|
TPO | thyroid peroxidase | 2p25 | 1.018 | 0.038 | 0.431
|
BRINP3 | bone morphogenetic protein/retinoic acid inducible neural-specific 3 | 1q31.1 | 1.016 | 0.142 | 0.0033
|
APOA2 | apolipoprotein A-II | 1q23.3 | 1.014 | 0.228 | 2.07e-06
|
LMO1 | LIM domain only 1 (rhombotin 1) | 11p15 | 1.006 | 0.11 | 0.0228
|
TUBA3E | tubulin, alpha 3e | 2q21.1 | 1.004 | 0.216 | 7.05e-06
|
SERPINB11 | serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene) | 18q21.33 | 1.001 | 0.052 | 0.282
|
LIN28B | lin-28 homolog B (C. elegans) | 6q21 | 0.997 | 0.372 | 1.82e-15
|
SLCO1B3 | solute carrier organic anion transporter family, member 1B3 | 12p12 | 0.995 | 0.312 | 5.41e-11
|
ORM1 | orosomucoid 1 | 9q32 | 0.991 | 0.24 | 5.35e-07
|
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter), member 1 | 14q24.2 | 0.988 | 0.087 | 0.0724
|
DSG4 | desmoglein 4 | 18q12.1 | 0.988 | 0.038 | 0.439
|
LHX1 | LIM homeobox 1 | 17q12 | 0.984 | 0.164 | 0.000686
|
RPTN | repetin | 1q21.3 | 0.984 | 0.113 | 0.0193
|
AACSP1 | acetoacetyl-CoA synthetase pseudogene 1 | 5q35 | 0.983 | 0.315 | 3.69e-11
|
KRT24 | keratin 24, type I | 17q21.2 | 0.982 | 0.147 | 0.0024
|
KLK5 | kallikrein-related peptidase 5 | 19q13.33 | 0.975 | 0.216 | 7.2e-06
|
SCGB1A1 | secretoglobin, family 1A, member 1 (uteroglobin) | 11q12.3 | 0.973 | 0.104 | 0.0322
|
PAK7 | p21 protein (Cdc42/Rac)-activated kinase 7 | 20p12 | 0.973 | 0.114 | 0.0189
|
SPRR2F | small proline-rich protein 2F | 1q21-q22 | 0.972 | 0.191 | 7.17e-05
|
AMTN | amelotin | 4q13.3 | 0.97 | 0.138 | 0.00426
|
SEMG1 | semenogelin I | 20q12-q13.2 | 0.969 | 0.05 | 0.299
|
KLK2 | kallikrein-related peptidase 2 | 19q13.33 | 0.968 | 0.165 | 0.000629
|
KHDC1L | KH homology domain containing 1-like | 6q13 | 0.967 | 0.33 | 3.26e-12
|
SLC6A15 | solute carrier family 6 (neutral amino acid transporter), member 15 | 12q21.31 | 0.966 | 0.163 | 0.00074
|
MAGEA12 | melanoma antigen family A12 | Xq28 | 0.965 | 0.423 | 0
|
NAP1L6 | nucleosome assembly protein 1-like 6 | Xq13.2 | 0.964 | 0.266 | 2.78e-08
|
CNKSR2 | connector enhancer of kinase suppressor of Ras 2 | Xp22.12 | 0.958 | -0.018 | 0.708
|
HS3ST4 | heparan sulfate (glucosamine) 3-O-sulfotransferase 4 | 16p11.2 | 0.954 | 0.105 | 0.0299
|
F2 | coagulation factor II (thrombin) | 11p11.2 | 0.95 | 0.121 | 0.0124
|
ZMAT4 | zinc finger, matrin-type 4 | 8p11.21 | 0.948 | 0.184 | 0.00014
|
TRIM15 | tripartite motif containing 15 | 6p21.33 | 0.943 | 0.247 | 2.63e-07
|
SUMO1P1 | SUMO1 pseudogene 1 | 20q13.2 | 0.941 | 0.195 | 5.03e-05
|
TPTE | transmembrane phosphatase with tensin homology | 21p11 | 0.941 | 0.267 | 2.51e-08
|
CFHR1 | complement factor H-related 1 | 1q32 | 0.94 | 0.075 | 0.122
|
SYT10 | synaptotagmin X | 12p11 | 0.937 | 0.018 | 0.71
|
CLEC3A | C-type lectin domain family 3, member A | 16q23 | 0.936 | 0.007 | 0.878
|
OOEP | oocyte expressed protein | 6q13 | 0.935 | 0.148 | 0.00213
|
ODAM | odontogenic, ameloblast asssociated | 4q13.3 | 0.932 | 0.056 | 0.244
|
KLK8 | kallikrein-related peptidase 8 | 19q13 | 0.932 | 0.19 | 8.09e-05
|
KRT75 | keratin 75, type II | 12q13.13 | 0.929 | 0.127 | 0.00879
|
MAGEA2 | melanoma antigen family A2 | Xq28 | 0.928 | 0.43 | 0
|
AMBP | alpha-1-microglobulin/bikunin precursor | 9q32-q33 | 0.927 | 0.116 | 0.0162
|
FSTL5 | follistatin-like 5 | 4q32.3 | 0.919 | 0.386 | 1.2e-17
|
SSTR5-AS1 | SSTR5 antisense RNA 1 | 16p13.3 | 0.919 | 0.009 | 0.86
|
CASR | calcium-sensing receptor | 3q21.1 | 0.918 | 0.095 | 0.0491
|
SNTG1 | syntrophin, gamma 1 | 8q11.21 | 0.918 | 0.086 | 0.0769
|
UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 | 4q13.3 | 0.917 | 0.012 | 0.808
|
ASB5 | ankyrin repeat and SOCS box containing 5 | 4q34.1 | 0.915 | 0.022 | 0.655
|
PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 20q13.31 | 0.912 | 0.075 | 0.123
|
KCNJ16 | potassium channel, inwardly rectifying subfamily J, member 16 | 17q24.3 | 0.91 | 0.101 | 0.0373
|
ZNF676 | zinc finger protein 676 | 19p12 | 0.909 | 0.225 | 2.69e-06
|
LIPK | lipase, family member K | 10q23.31 | 0.907 | 0.078 | 0.109
|
CSMD3 | CUB and Sushi multiple domains 3 | 8q23.3 | 0.901 | 0.232 | 1.4e-06
|
PIP | prolactin-induced protein | 7q34 | 0.897 | 0.028 | 0.563
|
ARSF | arylsulfatase F | Xp22.3 | 0.896 | 0.015 | 0.759
|
C11orf87 | chromosome 11 open reading frame 87 | 11q22.3 | 0.894 | 0.054 | 0.266
|
PAEP | progestagen-associated endometrial protein | 9q34 | 0.892 | 0.211 | 1.1e-05
|
SOST | sclerostin | 17q12-q21 | 0.891 | 0.135 | 0.00525
|
LDHC | lactate dehydrogenase C | 11p15.1 | 0.885 | 0.14 | 0.00373
|
MLIP | muscular LMNA-interacting protein | 6p12.2-p12.1 | 0.884 | 0.063 | 0.193
|
ALX1 | ALX homeobox 1 | 12q21.31 | 0.884 | 0.192 | 6.71e-05
|
GSTA2 | glutathione S-transferase alpha 2 | 6p12.2 | 0.884 | 0.14 | 0.00375
|
SPDYC | speedy/RINGO cell cycle regulator family member C | 11q13.1 | 0.879 | 0.211 | 1.19e-05
|
MYPN | myopalladin | 10q22.1 | 0.878 | 0.095 | 0.0507
|
PSG5 | pregnancy specific beta-1-glycoprotein 5 | 19q13.2 | 0.875 | 0.099 | 0.0412
|
PLA2G3 | phospholipase A2, group III | 22q12.2 | 0.873 | 0.15 | 0.00184
|
HAND1 | heart and neural crest derivatives expressed 1 | 5q33 | 0.872 | 0.042 | 0.39
|
PCDHA12 | protocadherin alpha 12 | 5q31 | 0.871 | 0.107 | 0.0276
|
ADGRG7 | adhesion G protein-coupled receptor G7 | 3q12.3 | 0.87 | 0.148 | 0.00223
|
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 12q13.2-q13.3 | 0.869 | 0.1 | 0.038
|
ROS1 | ROS proto-oncogene 1 , receptor tyrosine kinase | 6q21-q22 | 0.867 | 0.179 | 0.00021
|
CFAP47 | cilia and flagella associated protein 47 | Xp21.1 | 0.866 | 0.19 | 7.93e-05
|
NXPH2 | neurexophilin 2 | 2q22.1 | 0.866 | 0.115 | 0.0175
|
FCAMR | Fc receptor, IgA, IgM, high affinity | 1q32.1 | 0.865 | -0.026 | 0.588
|
LINC00473 | long intergenic non-protein coding RNA 473 | 6q27 | 0.862 | 0.06 | 0.214
|
TCERG1L | transcription elongation regulator 1-like | 10q26.3 | 0.859 | -0.038 | 0.437
|
FAM224B | family with sequence similarity 224, member B (non-protein coding) | Yq11.221 | 0.859 | 0.101 | 0.0374
|
CDH19 | cadherin 19, type 2 | 18q22.1 | 0.859 | 0.217 | 6.58e-06
|
ANGPTL7 | angiopoietin-like 7 | 1p36 | 0.858 | -0.023 | 0.636
|
PCDHAC1 | protocadherin alpha subfamily C, 1 | 5q31 | 0.854 | 0.032 | 0.512
|
KLK7 | kallikrein-related peptidase 7 | 19q13.33 | 0.851 | 0.17 | 0.000436
|
KLF17 | Kruppel-like factor 17 | 1p34.1 | 0.842 | 0.078 | 0.108
|
SPRR2E | small proline-rich protein 2E | 1q21-q22 | 0.841 | 0.16 | 0.000922
|
ACTBL2 | actin, beta-like 2 | 5q11.2 | 0.836 | 0.134 | 0.00575
|
PCDHA11 | protocadherin alpha 11 | 5q31 | 0.834 | 0.133 | 0.0058
|
ZNF727 | zinc finger protein 727 | 7q11.21 | 0.833 | 0.207 | 1.69e-05
|
FAM181A | family with sequence similarity 181, member A | 14q32.12 | 0.829 | 0.129 | 0.00773
|
LINGO2 | leucine rich repeat and Ig domain containing 2 | 9p21.2 | 0.825 | 0.119 | 0.0138
|
KC6 | | | 0.823 | 0.291 | 1.12e-09
|
MYO3A | myosin IIIA | 10p11.1 | 0.823 | 0.085 | 0.0805
|
SPINK7 | serine peptidase inhibitor, Kazal type 7 (putative) | 5q32 | 0.822 | 0.079 | 0.102
|
PENK | proenkephalin | 8q23-q24 | 0.822 | 0.054 | 0.268
|
SH3GL3 | SH3-domain GRB2-like 3 | 15q24 | 0.819 | 0.111 | 0.0216
|
FER1L6 | fer-1-like family member 6 | 8q24.13 | 0.818 | -0.071 | 0.142
|
LYPD2 | LY6/PLAUR domain containing 2 | 8q24.3 | 0.818 | 0.152 | 0.00162
|
SDR9C7 | short chain dehydrogenase/reductase family 9C, member 7 | 12q13.3 | 0.817 | 0.141 | 0.00356
|
GGT8P | gamma-glutamyltransferase 8 pseudogene | 2p11.1 | 0.816 | 0.152 | 0.00167
|
SLITRK3 | SLIT and NTRK-like family, member 3 | 3q26.1 | 0.815 | 0.057 | 0.241
|
ALPPL2 | alkaline phosphatase, placental-like 2 | 2q37 | 0.813 | 0.177 | 0.000251
|
FAM133A | family with sequence similarity 133, member A | Xq21.32 | 0.808 | 0.422 | 0
|
HAVCR1 | hepatitis A virus cellular receptor 1 | 5q33.2 | 0.806 | 0.116 | 0.0165
|
GABRQ | gamma-aminobutyric acid (GABA) A receptor, theta | Xq28 | 0.803 | 0.094 | 0.053
|
ARX | aristaless related homeobox | Xp21.3 | 0.803 | 0.17 | 0.000436
|
UTS2 | urotensin 2 | 1p36 | 0.802 | 0.097 | 0.0458
|
PAPPA2 | pappalysin 2 | 1q25.2 | 0.8 | 0.086 | 0.0759
|
KLK13 | kallikrein-related peptidase 13 | 19q13.33 | 0.798 | 0.098 | 0.044
|
KRT40 | keratin 40, type I | 17q21.2 | 0.798 | 0.039 | 0.417
|
KRTDAP | keratinocyte differentiation-associated protein | 19q13.12 | 0.798 | 0.208 | 1.57e-05
|
RIMS1 | regulating synaptic membrane exocytosis 1 | 6q12-q13 | 0.795 | 0.052 | 0.287
|
HSPB3 | heat shock 27kDa protein 3 | 5q11.2 | 0.795 | 0.038 | 0.434
|
IL20 | interleukin 20 | 1q32 | 0.795 | 0.03 | 0.531
|
MYH16 | myosin, heavy chain 16 pseudogene | 7q22.1 | 0.794 | 0.102 | 0.0353
|
UGT1A7 | UDP glucuronosyltransferase 1 family, polypeptide A7 | 2q37 | 0.79 | 0.077 | 0.112
|
PSG4 | pregnancy specific beta-1-glycoprotein 4 | 19q13.2 | 0.784 | 0.064 | 0.189
|
C1orf110 | coiled-coil domain containing 190 | 1q23.3 | 0.779 | 0.047 | 0.331
|
BCORP1 | BCL6 corepressor pseudogene 1 | Yq11.222 | 0.779 | 0.033 | 0.494
|
ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 4q23 | 0.775 | 0.083 | 0.085
|
VCX | variable charge, X-linked | Xp22.31 | 0.774 | 0.32 | 1.62e-11
|
LINC01139 | long intergenic non-protein coding RNA 1139 | 1q43 | 0.774 | 0.246 | 3e-07
|
NRXN1 | neurexin 1 | 2p16.3 | 0.773 | -0.044 | 0.368
|
PLA2G4E | phospholipase A2, group IVE | 15q15.1 | 0.772 | 0.083 | 0.0851
|
SAA4 | serum amyloid A4, constitutive | 11p15.1-p14 | 0.764 | 0.088 | 0.0692
|
CGB8 | chorionic gonadotropin, beta polypeptide 8 | 19q13.32 | 0.761 | 0.149 | 0.00199
|
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 1p12 | 0.761 | 0.078 | 0.108
|
TTTY14 | testis-specific transcript, Y-linked 14 (non-protein coding) | Yq11.222 | 0.76 | 0.035 | 0.471
|
FEZF1 | FEZ family zinc finger 1 | 7q31.32 | 0.739 | 0.054 | 0.266
|
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | 12q12 | 0.738 | 0.279 | 4.98e-09
|
S100A7A | S100 calcium binding protein A7A | 1q22 | 0.738 | 0.214 | 8.21e-06
|
TMPRSS11D | transmembrane protease, serine 11D | 4q13.2 | 0.731 | 0.057 | 0.239
|
CSMD1 | CUB and Sushi multiple domains 1 | 8p23.2 | 0.724 | 0.176 | 0.000258
|
VIT | vitrin | 2p22.2 | 0.723 | 0.031 | 0.52
|
SMPX | small muscle protein, X-linked | Xp22.2-p22.1 | 0.718 | 0.096 | 0.0478
|
CLDN6 | claudin 6 | 16p13.3 | 0.716 | 0.088 | 0.0702
|
NYAP2 | neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 | 2q36.3 | 0.706 | 0.055 | 0.253
|
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 2q24 | 0.702 | 0.023 | 0.637
|
LINC00518 | long intergenic non-protein coding RNA 518 | 6p24.3 | 0.699 | 0.1 | 0.0384
|
EPYC | epiphycan | 12q21 | 0.698 | 0.124 | 0.0105
|
SLC30A10 | solute carrier family 30, member 10 | 1q41 | 0.698 | 0.171 | 0.000398
|
FCRL1 | Fc receptor-like 1 | 1q21-q22 | 0.695 | 0.012 | 0.81
|
EPGN | epithelial mitogen | 4q13.3 | 0.692 | 0.122 | 0.0114
|
ASTN1 | astrotactin 1 | 1q25.2 | 0.689 | 0.089 | 0.0669
|
CLEC17A | C-type lectin domain family 17, member A | 19p13.12 | 0.688 | 0.033 | 0.503
|
MAGEA4 | melanoma antigen family A4 | Xq28 | 0.684 | 0.327 | 5.46e-12
|
CPLX2 | complexin 2 | 5q35.2 | 0.679 | -0.066 | 0.173
|
FAM25BP | family with sequence similarity 25, member B, pseudogene | 10q11.22 | 0.672 | 0.024 | 0.625
|
ACTL8 | actin-like 8 | 1p36.13 | 0.671 | 0.247 | 2.48e-07
|
SFTA2 | surfactant associated 2 | 6p21.3 | 0.658 | 0.023 | 0.631
|
ZPLD1 | zona pellucida-like domain containing 1 | 3q12.3 | 0.651 | 0.084 | 0.0842
|
CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 10q24.1 | 0.648 | 0.04 | 0.413
|
KLF14 | Kruppel-like factor 14 | 7q32.3 | 0.647 | 0.242 | 4.77e-07
|
FDCSP | follicular dendritic cell secreted protein | 4q13 | 0.641 | 0.086 | 0.0775
|
NUPR1L | nuclear protein, transcriptional regulator, 1-like | 7p11.2 | 0.633 | 0.101 | 0.0365
|
PRAC2 | prostate cancer susceptibility candidate 2 | 17q21.3 | 0.624 | 0.061 | 0.205
|
ZFP57 | ZFP57 zinc finger protein | 6p22.1 | 0.623 | 0.086 | 0.0747
|
TMPRSS11A | transmembrane protease, serine 11A | 4q13.2 | 0.621 | 0.003 | 0.945
|
PCDHA2 | protocadherin alpha 2 | 5q31 | 0.616 | 0.189 | 9.01e-05
|
KRT31 | keratin 31, type I | 17q21.2 | 0.612 | 0.099 | 0.041
|
INS-IGF2 | INS-IGF2 readthrough | 11p15.5 | 0.611 | 0.075 | 0.123
|
CES1P1 | carboxylesterase 1 pseudogene 1 | 16q12.2 | 0.607 | -0.044 | 0.366
|
PCDHA1 | protocadherin alpha 1 | 5q31 | 0.584 | 0.153 | 0.00156
|
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 19p13.3 | 0.576 | 0.028 | 0.563
|
CXorf49B | chromosome X open reading frame 49B | Xq13.1 | 0.56 | 0.003 | 0.951
|
DSC1 | desmocollin 1 | 18q12.1 | 0.53 | 0.07 | 0.15
|
TSIX | TSIX transcript, XIST antisense RNA | Xq13.2 | 0.529 | 0.101 | 0.0371
|
TFF2 | trefoil factor 2 | 21q22.3 | 0.522 | 0.107 | 0.0274
|
RNF186 | ring finger protein 186 | 1p36.13 | 0.52 | 0.003 | 0.945
|
PGLYRP3 | peptidoglycan recognition protein 3 | 1q21 | 0.519 | 0.103 | 0.0336
|
CSAG1 | chondrosarcoma associated gene 1 | Xq28 | 0.514 | 0.416 | 0
|
ALDOB | aldolase B, fructose-bisphosphate | 9q21.3-q22.2 | 0.501 | -0.054 | 0.27
|
SLC47A2 | solute carrier family 47 (multidrug and toxin extrusion), member 2 | 17p11.2 | 0.498 | 0.129 | 0.00774
|
SNORD116-4 | small nucleolar RNA, C/D box 116-4 | 15q11.2 | 0.494 | -0.125 | 0.00971
|
NBPF4 | neuroblastoma breakpoint family, member 4 | 1p13.3 | 0.458 | 0.159 | 0.000974
|
TMSB4Y | thymosin beta 4, Y-linked | Yq11.221 | 0.431 | 0.024 | 0.622
|
MAGEA6 | melanoma antigen family A6 | Xq28 | 0.426 | 0.41 | 0
|
TRPM8 | transient receptor potential cation channel, subfamily M, member 8 | 2q37 | 0.417 | -0.009 | 0.849
|
MAGEA3 | melanoma antigen family A3 | Xq28 | 0.415 | 0.393 | 0
|
TPSD1 | tryptase delta 1 | 16p13.3 | 0.409 | 0.054 | 0.261
|
KLRC3 | killer cell lectin-like receptor subfamily C, member 3 | 12p13 | 0.401 | 0.036 | 0.454
|
MKRN3 | makorin ring finger protein 3 | 15q11-q13 | 0.399 | 0.347 | 2.23e-13
|
BAGE2 | B melanoma antigen family, member 2 | 21p11.2 | 0.394 | 0.208 | 1.59e-05
|
NBEAP1 | neurobeachin pseudogene 1 | 15q11.2 | 0.382 | 0.205 | 2.11e-05
|
CACNA2D1 | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | 7q21-q22 | 0.38 | -0.048 | 0.323
|
CASP14 | caspase 14, apoptosis-related cysteine peptidase | 19p13.1 | 0.365 | 0.05 | 0.299
|
HNF4A | hepatocyte nuclear factor 4, alpha | 20q13.12 | 0.359 | 0.12 | 0.0132
|
GTSF1 | gametocyte specific factor 1 | 12q13.2 | 0.346 | 0.296 | 5.27e-10
|
GTF2IRD1P1 | GTF2I repeat domain containing 1 pseudogene 1 | 7q11.21 | 0.344 | 0.041 | 0.394
|
PCDHA4 | protocadherin alpha 4 | 5q31 | 0.334 | 0.111 | 0.0217
|
GUCY2D | guanylate cyclase 2D, membrane (retina-specific) | 17p13.1 | 0.332 | 0.129 | 0.00759
|
TTTY15 | testis-specific transcript, Y-linked 15 (non-protein coding) | Yq11.1 | 0.331 | 0.019 | 0.691
|
C5orf58 | chromosome 5 open reading frame 58 | 5q35.1 | 0.309 | 0.163 | 0.000714
|
GPR156 | G protein-coupled receptor 156 | 3q13.33 | 0.304 | 0.077 | 0.111
|
TENM1 | teneurin transmembrane protein 1 | Xq25 | 0.301 | 0.328 | 4.9e-12
|
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Xq23 | 0.3 | 0.24 | 5.49e-07
|
EGFL8 | EGF-like-domain, multiple 8 | 6p21 | 0.299 | 0.135 | 0.00536
|
KLK14 | kallikrein-related peptidase 14 | 19q13.3-q13.4 | 0.298 | 0.131 | 0.00661
|
RPS15 | ribosomal protein S15 | 19p13.3 | 0.292 | 0.114 | 0.0186
|
FAM168A | family with sequence similarity 168, member A | 11q13.4 | 0.282 | -0.143 | 0.00318
|
C12orf56 | chromosome 12 open reading frame 56 | 12q14.2 | 0.278 | 0.165 | 0.000638
|
SLC28A3 | solute carrier family 28 (concentrative nucleoside transporter), member 3 | 9q21.33 | 0.278 | 0.018 | 0.713
|
LDOC1L | leucine zipper, down-regulated in cancer 1-like | 22q13.3 | 0.274 | -0.224 | 3.23e-06
|
MSS51 | MSS51 mitochondrial translational activator | 10q22.3 | 0.273 | 0.091 | 0.0597
|
NME3 | NME/NM23 nucleoside diphosphate kinase 3 | 16q13.3 | 0.268 | 0.023 | 0.634
|
ZFY | zinc finger protein, Y-linked | Yp11.3 | 0.264 | -0.072 | 0.138
|
SMC1A | structural maintenance of chromosomes 1A | Xp11.22-p11.21 | 0.263 | -0.068 | 0.161
|
GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | Xq28 | 0.254 | 0.123 | 0.0112
|
KCNK9 | potassium channel, two pore domain subfamily K, member 9 | 8q24.3 | 0.231 | 0.165 | 0.000636
|
KLHL7 | kelch-like family member 7 | 7p15.3 | 0.229 | 0.139 | 0.00392
|
CALB1 | calbindin 1, 28kDa | 8q21.3 | 0.228 | 0.139 | 0.00413
|
CGB5 | chorionic gonadotropin, beta polypeptide 5 | 19q13.32 | 0.224 | 0.194 | 5.65e-05
|
RAG1 | recombination activating gene 1 | 11p13 | 0.214 | 0.166 | 0.000565
|
ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 2p24 | 0.213 | 0.01 | 0.836
|
MYT1 | myelin transcription factor 1 | 20q13.33 | 0.211 | 0 | 0.997
|
NLRP2 | NLR family, pyrin domain containing 2 | 19q13.42 | 0.208 | 0.103 | 0.034
|
FAM98A | family with sequence similarity 98, member A | 2p22.3 | 0.2 | 0.185 | 0.000129
|
CSAG3 | CSAG family, member 3 | Xq28 | 0.199 | 0.305 | 1.56e-10
|
GPR158 | G protein-coupled receptor 158 | 10p12.31 | 0.199 | 0.237 | 8.05e-07
|
ABI2 | abl-interactor 2 | 2q33 | 0.198 | -0.127 | 0.00884
|
TMEM80 | transmembrane protein 80 | 11p15.5 | 0.195 | -0.207 | 1.77e-05
|
NICN1 | nicolin 1 | 3p21.31 | 0.193 | -0.093 | 0.0558
|
NRIP3 | nuclear receptor interacting protein 3 | 11p15.3 | 0.19 | 0.035 | 0.469
|
CAMLG | calcium modulating ligand | 5q23 | 0.178 | -0.106 | 0.0282
|
SAP30L | SAP30-like | 5q33.2 | 0.177 | -0.218 | 5.83e-06
|
N4BP2L1 | NEDD4 binding protein 2-like 1 | 13q13.1 | 0.169 | -0.141 | 0.00358
|